We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PATENT EXPIRIES WILL HIT DEPRESSION DRUG MARKET HARD
PATENT EXPIRIES WILL HIT DEPRESSION DRUG MARKET HARD
March 23, 2004
Generic competition on selective serotonin reuptake inhibitor (SSRI) products during the next decade will significantly limit growth in the major depression drug market in the U.S., according to a new study by Decision Resources.